Xenomics

exponential genomics inc. (xenomics) has built a team of scientists trained at harvard and mit that utilize genetically modified microorganisms to manufacture compounds identical to those found in nature. the core technology is a novel gene-editing technique capable of performing over 400 years of crispr in 8 weeks. current commercialization projects include streamlining the manufacturing of biopharmaceuticals, vaccines, breastmilk, cell therapies, cultured meats & dairy, water desalination, cannabinoid nutraceuticals, pharma-psychedelics, food flavors, and perfume scents.